CWM
COGT icon

CIBC World Markets’s Cogent Biosciences COGT Stock Holding History

CIBC World Markets’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$327K Buy
+9,197
New +$259K ﹤0.01% 924
2025
Q2 		$93.9K Sell
13,081
-7,280
-36% -$40.4K ﹤0.01% 1409
2025
Q1 		$122K Buy
+20,361
New +$160K ﹤0.01% 1566

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIBC World Markets's COGT Position: Q4 2025 in Review

CIBC World Markets opened a new position in Cogent Biosciences (COGT) in Q4 2025: 9,197 shares worth $327K. The stake represents ﹤0.01% of the portfolio and ranks #924 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in COGT as recently as Q2 2025.

CIBC World Markets first reported a position in COGT in Q1 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • CIBC World Markets held 9,197 shares of Cogent Biosciences worth $327K as of Q4 2025.
  • Cogent Biosciences was a new CIBC World Markets position in Q4 2025.
  • Cogent Biosciences made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #924 holding.
  • CIBC World Markets first reported a position in Cogent Biosciences in Q1 2025 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.